Article
Calpastatin overexpression in the skeletal muscle of mice prevents clenbuterol-induced muscle hypertrophy and phenotypic shift.
Clinical and experimental pharmacology & physiology - 1 Apr 2012
Douillard Aymeric, Galbes Olivier, Begue Gwenaelle, Rossano Bernadette, Levin John, Vernus Barbara, Bonnieu Anne, Candau Robin, Py Guillaume
Abstract excerpt
Accumulating evidence suggests that the calpain/calpastatin system is involved in skeletal muscle remodelling induced by β(2) -adrenoceptor agonist treatment. In addition to other pathways, the Akt/mammalian target of rapamycin (mTOR) pathway, controlling protein synthesis, and the calcium/calmodulin-dependent protein kinase 2 (CamK2) and AMP-activated protein kinase (AMPK) pathways, recently identified as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
